Position in RCUS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,757,350
+$1,541,123 QoQ
Shares Held
219,181
-9.2% QoQ
Ownership
0.172%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#50
of 230 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. RCUS ranks #40 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in RCUS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,757,350 | 219,181 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,216,227 | 241,492 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,412,889 | 227,146 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,851,049 | 209,636 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,712,289 | 210,355 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,435,835 | 182,909 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $2,371,440 | 159,264 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $2,474,457 | 161,835 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,525,667 | 165,835 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,260,066 | 172,673 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,272,555 | 171,338 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,048,789 | 169,849 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,367,113 | 165,786 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $3,029,317 | 166,081 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,371,605 | 163,037 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,142,566 | 158,355 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,693,228 | 145,747 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,919,479 | 60,820 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,647,425 | 65,417 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,284,089 | 65,503 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,799,398 | 65,528 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,341,465 | 47,773 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,333,331 | 51,361 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $792,467 | 46,235 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,210,330 | 48,922 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $754,489 | 54,358 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||